JENNA CAVANAUGH: Open Payments
NPI 1558102038 · PINEHURST, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$992 in 32 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $678 · 2025 $992
Food & beverage: $915Education: $77
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $380 |
| Pharmacosmos Therapeutics Inc. | 1 | $150 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $135 |
| Janssen Biotech, Inc. | 3 | $132 |
| Ardelyx, Inc. | 4 | $79 |
| Novo Nordisk Inc | 1 | $24 |
| Lilly USA, LLC | 1 | $22 |
| Intercept Pharmaceuticals, Inc. | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Phathom Pharmaceuticals, Inc. | 2 | $17 |
Products named: RINVOQ, MONOFERRIC, XIFAXAN, TREMFYA, IBSRELA, CREON, SKYRIZI, LINZESS.
Industry payments across NC — which companies pay providers there.
